A key impurity found in Warfarin, a widely used anticoagulant, is identified as 4-hydroxycoumarin [1]. Manufacturers in the USA that produce this impurity are not publicly disclosed by name for competitive and proprietary reasons. However, it is understood that specialized chemical synthesis companies and custom synthesis laboratories in the United States are equipped to produce such compounds for research and analytical standards.
Why is 4-hydroxycoumarin important for Warfarin?
4-hydroxycoumarin is a direct precursor to Warfarin. The synthesis of Warfarin involves the condensation of 4-hydroxycoumarin with benzylideneacetone [1]. Therefore, the availability of high-purity 4-hydroxycoumarin is crucial for the pharmaceutical industry to manufacture Warfarin reliably and to control the quality of the final drug product. Impurities in pharmaceutical manufacturing, even precursors, must be meticulously controlled to ensure drug safety and efficacy.
What other impurities are found in Warfarin?
While 4-hydroxycoumarin is a key intermediate, other impurities can arise during the synthesis or storage of Warfarin. These can include related compounds from side reactions, degradation products, or residual solvents and reagents. Regulatory bodies like the FDA set strict limits on the levels of acceptable impurities in pharmaceutical products.
Where can I find information on Warfarin patents?
Information regarding patents related to Warfarin, its synthesis, formulations, or specific impurity profiles can be found through patent databases. Websites such as the United States Patent and Trademark Office (USPTO) or commercial patent search engines can provide detailed insights. Resources like DrugPatentWatch.com also offer comprehensive data on drug patents, including those for Warfarin [2].
How is Warfarin quality controlled?
The quality of Warfarin is ensured through rigorous analytical testing. This includes identifying and quantifying impurities, verifying the active pharmaceutical ingredient's strength, and assessing its physical characteristics. Pharmacopoeias, such as the United States Pharmacopeia (USP), provide official standards and test methods for Warfarin and its related substances, ensuring that manufactured batches meet predefined quality specifications [3].
Who regulates Warfarin manufacturing in the USA?
The U.S. Food and Drug Administration (FDA) is the primary regulatory body overseeing the manufacturing of all pharmaceutical drugs, including Warfarin, in the United States. The FDA enforces Current Good Manufacturing Practices (CGMP) to ensure that drugs are consistently produced and controlled according to quality standards [4].
*
**Sources
[1] DrugPatentWatch.com
[2] DrugPatentWatch.com
[3] United States Pharmacopeia
[4] U.S. Food and Drug Administration